comparemela.com

Latest Breaking News On - Venture partners investment advisor - Page 1 : comparemela.com

Frazier Life Sciences Management L.P. Has $28.31 Million Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Larry-todd-edwards
Cantor-fitzgerald
Arcutis-biotherapeutics
Patrick-burnett
Capital-management
Ghisallo-capital-management
Needham-company
Nasdaq
Arcutis-biotherapeutics-inc
Securities-exchange-commission
Goldman-sachs-group
Venture-partners-investment-advisor

Frazier Life Sciences Management L.P. Has $28.31 Million Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Larry-todd-edwards
Patrick-burnett
Arcutis-biotherapeutics
Cantor-fitzgerald
Nasdaq
Goldman-sachs-group
Securities-exchange-commission
Arcutis-biotherapeutics-inc
Venture-partners-investment-advisor
Frazier-life-sciences-management
Ghisallo-capital-management
Capital-management

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Given Consensus Recommendation of "Hold" by Brokerages

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) has received an average recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages […]

Piper-sandler
Stifel-nicolaus
Venture-partners-investment-advisor
Wells-fargo-company
Nasdaq
Gracell-biotechnologies-inc
Sphera-funds-management
Vivo-capital
Gracell-biotechnologies
Get-free-report
Funds-management
Bay-capital-management

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc. (NASDAQ:GRCL)

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc. (NASDAQ:GRCL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus
Sphera-funds-management
Vivo-capital
Capital-group-international-inc
Wells-fargo-company
Gracell-biotechnologies-inc
Venture-partners-investment-advisor
Nasdaq
Fny-investment-advisers
Gracell-biotechnologies
Free-report
Funds-management

Adage Capital Partners GP L.L.C. Acquires New Holdings in Gracell Biotechnologies Inc. (NASDAQ:GRCL)

Adage Capital Partners GP L.L.C. bought a new position in Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund bought 850,000 shares of the company’s stock, valued at approximately $2,448,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vivo Capital LLC […]

Stifel-nicolaus
Piper-sandler
Vivo-capital
Capital-group-international-inc
Nasdaq
Venture-partners-investment-advisor
Wells-fargo-company
Sphera-funds-management
Cantor-fitzgerald
Gracell-biotechnologies-inc
Adage-capital-partners
Gracell-biotechnologies

vimarsana © 2020. All Rights Reserved.